First human tests for new autoimmune drug complete
NCT ID NCT06488209
Summary
This was the first study in people to test the safety of a new drug called LAD191, which is being developed for autoimmune diseases. It involved 69 healthy volunteers and people with an autoimmune condition. The main goal was to see how safe different doses were and to understand how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Doral Medical Research
Miami, Florida, 33165, United States
-
ICON Early Phase Services, LLC
San Antonio, Texas, 78209, United States
-
Jennifer Parish, MD
Philadelphia, Pennsylvania, 19103, United States
Conditions
Explore the condition pages connected to this study.